FUDR
FLOXURIDINE
Approval overview FUDR is listed in Drugs@FDA under application 016929 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient FLOXURIDINE Form and strength INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor HOSPIRA Submission history Latest submission status date: 1999-09-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview FUDR is listed in Drugs@FDA under application 016929 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient FLOXURIDINE Form and strength INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor HOSPIRA Submission history Latest submission status date: 1999-09-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.